the aid library

LIST OPTIONS

Filter

4239

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (609)

View PDF (875)

Knowledge, Attitudes and Practice surveys Zika virus disease and potential complications. Resource pack

World Health Organization (2016) C_WHO

This is a resource pack for a Knowledge, Attitudes and Practices (KAP) surveys about Zika virus and its suspected complications such as microcephaly and Guillain-Barré syndrome. This resource and associated advice was requested by governments and response partners as a way to rapidly obtain valuab... more

Download (2234)

View PDF (2125)

WHO Safe Childbirth Checklist Implementation Guide
recommended

World Health Organization WHO (2015) C_WHO

This implementation guide has been developed to help birth attendants and health-care leaders successfully launch and sustain use of the WHO Safe Childbirth Checklist. Development, use and implementation of the Checklist are described in this guide. It covers how to introduce and ensure continuous ... more

Download (876)

View PDF (1584)

Field Manual PAHO/WHO Regional Disaster Response Team

Pan American Health Organization PAHOWHO (2010)

Download (729)

View PDF (789)

Infant and young child feeding counselling: an integrated course: participant's manual
recommended

World Health Organization WHO; UNICEF (2021) C_WHO

The Participant’s manual contains summaries of information presented by the trainers, copies of worksheets and checklists for the clinical practice and practical sessions, and exercises that participants will do during the course. One manual should be provided for each participant, using the modul... more

Download (487)

View PDF (915)

Manual on Cyclone: Causes, Effects & Preparedness

The Republic of the Union of Myanmar, Relief and Resettlement Department; UN-Habitat (2010) C1

No publication year indicated.

External Link

Rapid Health Assessment Protocols for Emergencies

World Health Organization WHO (1999) C_WHO

Download (1313)

View PDF (2508)

Guideline for Hand Hygiene in Health-Care Settings

Centers for Disease Control and Prevention CDC (2002)

Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force

Download (356)

View PDF (840)

A practical guide for communicating global justice and solidarity - An alternative to the language of development, aid and charity
recommended

Health Poverty Action (2019) C1

The way we talk about global issues affects how people think, feel and react to them. Recognising that language has the power to create social change, we have produced this guide with the inten-tion of setting out a different approach to communicating global issues—one that replaces the nar-rative... more

Download (456)

View PDF (398)

Infection prevention and control in primary care: a toolkit of resources
recommended

World Health Organization WHO (2021) C_WHO

The recently published World Health Organization (WHO) Strengthening infection prevention and control in primary care document collates existing standards, measurement and implementation approaches, and resources for infection prevention and control (IPC) in primary care. During its development, it ... more

Download (855)

View PDF (2103)

Working with Individuals, Families and Communities to Improve Maternal and Newborn Health. Module 5

World Health Organization WHO; PAHO Pan American Health Organization, Enfant du Monde (2017) C_WHO

A Toolkit for Implementation. Module 5: Finalizing, monitoring and evaluating the IFC action plan

Download (420)

View PDF (542)

Policies to protect children from the harmful impact of food marketing: WHO guideline

World Health Organisation (WHO) (2023) C_WHO

Children continue to be exposed to powerful food marketing, which predominantly promotes foods high in saturated fatty acids, trans-fatty acids, free sugars and/or sodium and uses a wide variety of marketing strategies that are likely to appeal to children. Food marketing has a harmful impact on chi... more

Download (1032)

View PDF (2757)

Guidance for health sector assessment to support the post-disaster recovery process

United Nations agencies, the World Bank and the European Commission (2010)

Download (533)

View PDF (711)

Sexual Violence in Detention

International Committee of the Red Cross (ICRC) (2017) C1

We have long been working to prevent and end sexual violence in armed conflicts and to ensure that the countless victims – men, women, boys and girls – receive the help they need.
In this document, we examine sexual violence specifically in relation to people deprived of their liberty. We c... more